Annual Total Debt
$75.86 M
-$9.58 M-11.22%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual total debt is $75.86 million, with the most recent change of -$9.58 million (-11.22%) on December 31, 2023.
- During the last 3 years, IOVA annual total debt has risen by +$24.20 million (+46.85%).
- IOVA annual total debt is now -11.22% below its all-time high of $85.45 million, reached on December 31, 2022.
Performance
IOVA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$78.94 M
-$2.74 M-3.36%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly total debt is $78.94 million, with the most recent change of -$2.74 million (-3.36%) on September 30, 2024.
- Over the past year, IOVA quarterly total debt has dropped by -$5.43 million (-6.43%).
- IOVA quarterly total debt is now -7.61% below its all-time high of $85.45 million, reached on December 31, 2022.
Performance
IOVA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
IOVA Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -6.4% |
| 3 y3 years | +46.9% | -1.9% |
| 5 y5 years | +100.0% | -1.9% |
IOVA Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.2% | +6.0% | -7.6% | +10.4% |
| 5 y | 5-year | -11.2% | +559.7% | -7.6% | +902.5% |
| alltime | all time | -11.2% | -100.0% | -7.6% | -100.0% |
Iovance Biotherapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $78.94 M(-3.4%) |
| Jun 2024 | - | $81.68 M(-3.2%) |
| Mar 2024 | - | $84.37 M(+11.2%) |
| Dec 2023 | $75.86 M(-11.2%) | $75.86 M(-4.5%) |
| Sep 2023 | - | $79.48 M(-1.5%) |
| Jun 2023 | - | $80.71 M(-3.0%) |
| Mar 2023 | - | $83.23 M(-2.6%) |
| Dec 2022 | $85.45 M(+19.5%) | $85.45 M(+6.7%) |
| Sep 2022 | - | $80.11 M(-0.5%) |
| Jun 2022 | - | $80.48 M(+0.7%) |
| Mar 2022 | - | $79.89 M(+11.7%) |
| Dec 2021 | $71.53 M(+38.5%) | $71.53 M(-1.1%) |
| Sep 2021 | - | $72.34 M(+38.4%) |
| Jun 2021 | - | $52.27 M(-3.2%) |
| Mar 2021 | - | $54.00 M(+4.5%) |
| Dec 2020 | $51.66 M(+349.2%) | $51.66 M(+373.6%) |
| Sep 2020 | - | $10.91 M(+38.5%) |
| Jun 2020 | - | $7.87 M(-17.3%) |
| Mar 2020 | - | $9.52 M(-17.2%) |
| Dec 2019 | $11.50 M(>+9900.0%) | $11.50 M(-20.1%) |
| Sep 2019 | - | $14.39 M(+18.9%) |
| Jun 2019 | - | $12.10 M(+15.9%) |
| Mar 2019 | - | $10.44 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $6.78 M(+4.6%) |
| Dec 2012 | $6.48 M(+29.6%) | $6.48 M(0.0%) |
| Sep 2012 | - | $6.48 M(+4.3%) |
| Jun 2012 | - | $6.22 M(+23.9%) |
| Mar 2012 | - | $5.02 M(+0.4%) |
| Dec 2011 | $5.00 M(>+9900.0%) | $5.00 M(+92.4%) |
| Sep 2011 | - | $2.60 M(>+9900.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00 |
FAQ
- What is Iovance Biotherapeutics annual total debt?
- What is the all time high annual total debt for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual total debt year-on-year change?
- What is Iovance Biotherapeutics quarterly total debt?
- What is the all time high quarterly total debt for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly total debt year-on-year change?
What is Iovance Biotherapeutics annual total debt?
The current annual total debt of IOVA is $75.86 M
What is the all time high annual total debt for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual total debt is $85.45 M
What is Iovance Biotherapeutics annual total debt year-on-year change?
Over the past year, IOVA annual total debt has changed by -$9.58 M (-11.22%)
What is Iovance Biotherapeutics quarterly total debt?
The current quarterly total debt of IOVA is $78.94 M
What is the all time high quarterly total debt for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly total debt is $85.45 M
What is Iovance Biotherapeutics quarterly total debt year-on-year change?
Over the past year, IOVA quarterly total debt has changed by -$5.43 M (-6.43%)